Detailed information for compound 368402

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 488.466 | Formula: C24H26F6N2O2
  • H donors: 1 H acceptors: 1 LogP: 4.43 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(C(=O)[C@]1(N)C[C@@](C1)(CO[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)c1ccccc1)C
  • InChi: 1S/C24H26F6N2O2/c1-15(16-9-18(23(25,26)27)11-19(10-16)24(28,29)30)34-14-21(17-7-5-4-6-8-17)12-22(31,13-21)20(33)32(2)3/h4-11,15H,12-14,31H2,1-3H3/t15-,21-,22+/m1/s1
  • InChiKey: LQRDBJSVJUNPHC-RTOPAQNCSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens tachykinin receptor 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K04224 tachykinin receptor 3, putative Get druggable targets OG5_137770 All targets in OG5_137770
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major guanosine monophosphate reductase 0.0244 0.5455 0.5
Plasmodium vivax inosine-5'-monophosphate dehydrogenase, putative 0.023 0.49 0.5
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) 0.0244 0.5455 1
Trypanosoma cruzi GMP reductase 0.0244 0.5455 0.5
Schistosoma mansoni inosine-5-monophosphate dehydrogenase 0.0244 0.5455 0.5
Leishmania major inosine-5-monophosphate dehydrogenase 0.0244 0.5455 0.5
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0244 0.5455 0.5
Mycobacterium ulcerans inosine 5'-monophosphate dehydrogenase 0.0244 0.5455 1
Toxoplasma gondii IMP dehydrogenas 0.0244 0.5455 0.5
Trypanosoma cruzi GMP reductase 0.0244 0.5455 0.5
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0244 0.5455 0.5
Echinococcus multilocularis tachykinin peptides receptor 99D 0.0363 1 1
Onchocerca volvulus Putative GMP reductase 0.0101 0 0.5
Trypanosoma brucei inosine-5'-monophosphate dehydrogenase 0.0244 0.5455 0.5
Wolbachia endosymbiont of Brugia malayi IMP dehydrogenase 0.0244 0.5455 0.5
Brugia malayi inosine-5'-monophosphate dehydrogenase family protein 0.0244 0.5455 1
Mycobacterium ulcerans inosine 5-monophosphate dehydrogenase 0.023 0.49 0.8869
Plasmodium falciparum inosine-5'-monophosphate dehydrogenase 0.023 0.49 0.5
Trypanosoma brucei GMP reductase 0.0244 0.5455 0.5
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0244 0.5455 0.5
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena 0.0128 0.1022 0.0954
Loa Loa (eye worm) IMP dehydrogenase 1 0.0244 0.5455 1
Mycobacterium tuberculosis Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase 0.0244 0.5455 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (functional) = 79 % Inhibition of GR73632-induced foot tapping in Mongolian gerbil at 1mg/kg, po after 4 hrs ChEMBL. 16682196
Ki (binding) = 3.3 nM Displacement of [3H]Sar-Met substance P from human recombinant NK1 receptor expressed in CHO cells ChEMBL. 16682196
Ki (binding) = 3.3 nM Displacement of [3H]Sar-Met substance P from human recombinant NK1 receptor expressed in CHO cells ChEMBL. 16682196

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.